精品亚洲一区二区三区在线播放,国产精品久久久久久久久免费,亚洲一区二区三区无码中文字幕,天天躁夜夜躁狠狠躁2021a2

技術(shù)文章您現(xiàn)在的位置:首頁 > 技術(shù)文章 > 人CXC趨化因子配體2(CXCL2)ELISA試劑盒引用文獻(xiàn)

人CXC趨化因子配體2(CXCL2)ELISA試劑盒引用文獻(xiàn)

更新時間:2022-01-04   點(diǎn)擊次數(shù):1103次

恒遠(yuǎn)產(chǎn)品文獻(xiàn):人CXC趨化因子配體2(CXCL2)ELISA試劑盒引用文獻(xiàn)

【文獻(xiàn)標(biāo)題】CXCL2-mediated ATR/CHK1 signaling pathway and?platinum resistance in?epithelial ovarian cancer

【作者】Sipei Nie, Yicong Wan, Hui Wang,et.al

【作者單位】南京醫(yī)科大學(xué)(Nanjing Medical University)

【文獻(xiàn)中引用產(chǎn)品】

人CXC趨化因子配體2(CXCL2)ELISA試劑盒

【關(guān)鍵詞】Epithelial ovarian cancer (EOC), Platinum-resistance, Chemokine, CXCL2

【DOI】doi.org/10.1186/s13048-021-00864-3

出版期刊】《RESEARCH》

【產(chǎn)品原文引用】

Enzyme?linked immunosorbent assay (ELISA)

Serum samples of platinum-resistant and platinum-sensitive patients and cell culture supernatants were respectively extracted for cytokine analysis. Human CXCL2 ELISA kits were purchased from Hengyuan? Biological Co. Ltd (Shanghai, China), and ELISA assay was performed as the manufacturers’ instructions. Each sample was duplicated.


聯(lián)